Rolf E. Brouwer

Efficacy and Safety of Outpatient Treatment Based on the Hestia Clinical Decision Rule with or without N-Terminal Pro–Brain Natriuretic Peptide Testing in Patients with Acute Pulmonary Embolism. A Randomized Clinical Trial

Paul L. den Exter, Wendy Zondag, Frederikus A. Klok et al. · American Journal of Respiratory and Critical Care Medicine · 2016 · 139 citations · Full text

Medicine, Clinical Sciences, Internal Medicine +9

Melphalan, prednisone, and lenalidomide versus melphalan, prednisone, and thalidomide in untreated multiple myeloma

Sonja Zweegman, Bronno van der Holt, Ulf‐Henrik Mellqvist et al. · Blood · 2016 · 112 citations · Full text

Medicine, Hematology, Oncology +14

Platelet doubling after the first azacitidine cycle is a promising predictor for response in myelodysplastic syndromes (MDS), chronic myelomonocytic leukaemia (CMML) and acute myeloid leukaemia (AML) patients in the Dutch azacitidine compassionate named patient programme

Lieke H. van der Helm, Canan Alhan, Pierre W. Wijermans et al. · British Journal of Haematology · 2011 · 106 citations · Full text

Medicine, Hematology, Pharmacology +11

Rituximab-CHOP With Early Rituximab Intensification for Diffuse Large B-Cell Lymphoma: A Randomized Phase III Trial of the HOVON and the Nordic Lymphoma Group (HOVON-84)

Pieternella J. Lugtenburg, Peter de Nully Brown, Bronno van der Holt et al. · Journal of Clinical Oncology · 2020 · 86 citations · Full text

Medicine, Oncology, Pharmacotherapy +7

One versus two years of elastic compression stockings for prevention of post-thrombotic syndrome (OCTAVIA study): randomised controlled trial

Gerben C. Mol, Marcel A. van de Ree, Frederikus A. Klok et al. · BMJ · 2016 · 83 citations · Full text

Medicine, Hematology, Hemostasis +14